These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31336100)

  • 21. Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.
    Dohgu S; Nishioku T; Sumi N; Takata F; Nakagawa S; Naito M; Tsuruo T; Yamauchi A; Shuto H; Kataoka Y
    Cell Mol Neurobiol; 2007 Nov; 27(7):889-99. PubMed ID: 17934807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligodendrocytes upregulate blood-brain barrier function through mechanisms other than the PDGF-BB/PDGFRα pathway in the barrier-tightening effect of oligodendrocyte progenitor cells.
    Kimura I; Dohgu S; Takata F; Matsumoto J; Watanabe T; Iwao T; Yamauchi A; Kataoka Y
    Neurosci Lett; 2020 Jan; 715():134594. PubMed ID: 31678431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury.
    Zhang WJ; Feng J; Zhou R; Ye LY; Liu HL; Peng L; Lou JN; Li CH
    Eur J Pharmacol; 2010 Dec; 648(1-3):146-52. PubMed ID: 20826144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury.
    Liu YL; Xu ZM; Yang GY; Yang DX; Ding J; Chen H; Yuan F; Tian HL
    Acta Pharmacol Sin; 2017 Nov; 38(11):1445-1455. PubMed ID: 28770828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier.
    Mysiorek C; Culot M; Dehouck L; Derudas B; Staels B; Bordet R; Cecchelli R; Fenart L; Berezowski V
    Curr Neurovasc Res; 2009 Aug; 6(3):181-93. PubMed ID: 19534718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
    Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
    Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydralazine is a Suitable Mimetic Agent of Hypoxia to Study the Impact of Hypoxic Stress on In Vitro Blood-Brain Barrier Model.
    Chatard M; Puech C; Perek N; Roche F
    Cell Physiol Biochem; 2017; 42(4):1592-1602. PubMed ID: 28738383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of Vitis vinifera L. phenolic compounds on a blood-brain barrier culture model: Expression of leptin receptors and protection against cytokine-induced damage.
    Ardid-Ruiz A; Harazin A; Barna L; Walter FR; Bladé C; Suárez M; Deli MA; Aragonès G
    J Ethnopharmacol; 2020 Jan; 247():112253. PubMed ID: 31562952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice.
    Zhao Q; Zhang F; Yu Z; Guo S; Liu N; Jiang Y; Lo EH; Xu Y; Wang X
    J Neuroinflammation; 2019 May; 16(1):103. PubMed ID: 31101061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
    Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
    Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALK-1 to ALK-5 ratio dictated by the Akt1-β-catenin pathway regulates TGFβ-induced endothelial-to-mesenchymal transition.
    Verma A; Artham S; Somanath PR
    Gene; 2021 Feb; 768():145293. PubMed ID: 33157202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions.
    Yang C; DeMars KM; Hawkins KE; Candelario-Jalil E
    Peptides; 2016 Jul; 81():29-37. PubMed ID: 27020249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertonic saline downregulates endothelial cell-derived VEGF expression and reduces blood-brain barrier permeability induced by cerebral ischaemia via the VEGFR2/eNOS pathway.
    Wang Q; Deng Y; Huang L; Zeng W; Chen S; Lv B; Jiang W; Han Y; Ding H; Wen M; Zeng H
    Int J Mol Med; 2019 Sep; 44(3):1078-1090. PubMed ID: 31524227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidic acid receptor, LPA
    Masago K; Kihara Y; Yanagida K; Hamano F; Nakagawa S; Niwa M; Shimizu T
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1048-1054. PubMed ID: 29778535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke.
    Kahles T; Luedike P; Endres M; Galla HJ; Steinmetz H; Busse R; Neumann-Haefelin T; Brandes RP
    Stroke; 2007 Nov; 38(11):3000-6. PubMed ID: 17916764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
    de Kroon LM; Narcisi R; Blaney Davidson EN; Cleary MA; van Beuningen HM; Koevoet WJ; van Osch GJ; van der Kraan PM
    PLoS One; 2015; 10(12):e0146124. PubMed ID: 26720610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-inducible factor-1α is involved in isoflurane-induced blood-brain barrier disruption in aged rats model of POCD.
    Cao Y; Li Z; Li H; Ni C; Li L; Yang N; Shi C; Zhong Y; Cui D; Guo X
    Behav Brain Res; 2018 Feb; 339():39-46. PubMed ID: 28887194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The underlying mechanisms of lorlatinib penetration across the blood-brain barrier and the distribution characteristics of lorlatinib in the brain.
    Chen W; Jin D; Shi Y; Zhang Y; Zhou H; Li G
    Cancer Med; 2020 Jun; 9(12):4350-4359. PubMed ID: 32347012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism.
    Engelhardt S; Al-Ahmad AJ; Gassmann M; Ogunshola OO
    J Cell Physiol; 2014 Aug; 229(8):1096-105. PubMed ID: 24375098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.